Christine Le Bec PhD

Christine Le Bec, Ph.D., joined Sensorion Pharma, a small biotech company, in early 2020 as Head of CMC Gene Therapy. She is responsible for CMC development (process and analytical development, product characterization) including non-clinical and clinical manufacturing, CMC transfer to CDMO/CRO, and CMC regulatory issues. Prior to joining Sensorion Pharma, she worked for more than 20 years at Genethon, a French non-profit organization, in the field of Gene Therapy vectors (AAV, lentivirus, baculovirus) for rare diseases. She has strong expertise in the development, qualification, and validation of analytical methods for product characterization, release testing of gene therapy products, and stability studies. She also has a solid knowledge of international regulations and reviewing CMC documents for clinical applications.